Monographie - Urokinase - Stabilis 4.0

Ultimele actualizari :
05/12/2025

Trombolitic

Urokinase

Injectabil

Stabilitatea in solutie

Stabilitatea in amestec

Factorii care influenteaza stabilitatea

Compatibilitate

Microunde

Bibliografie

pdf

Denumirea comerciala

Denumirea comerciala

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Abbokinase	Austria, SUA
Actosolv	Belgia, Franta, Luxemburg
Angikinase	Egipt
Corase	Germania
Dukinase	India
KD Unase	India
Medacinase	Olanda
Rheotromb	Ungaria
Syner-Kinase	Marea Britanie
Ukidan	Grecia
Urochinasi	Italia
Urokinase	Austria, Elvetia, Finlanda, Germania, Luxemburg, Malaezia, noua Zeelandă, Olanda, Spania
Uroquinasa	Chilli

Bibliografie

Injectabil

Bibliografie : Urokinase

	tip	publicare
375	ziar	Patel JP, Tran LT, Sinai WJ, Carr LJ. Activity of urokinase diluted in 0.9% sodium chloride injection or 5% dextrose injection and stored in glass or plastic syringes. Am J Hosp Pharm 1991 ; 48: 1511-1514.
1061	ziar	Rhoney DH, Coplin WM, Zaran FK, Brish LK, Weingarten CM. Urokinase after freezing : Implications for thrombolysis in intraventricular hemorrhage. Am J Health-Syst Pharm 1999 ; 56: 2047-2051.
1394	ziar	Zimmermann R, Sch?ffel G, Harenberg J. Urokinase therapy: dose reduction by administration in plastic material. Thromb Haemost 1981 ; 45: 296.
1395	ziar	Toki N, Sumi H. Glass adsorption of highly purified urokinase. Thromb Haemost 1980 ; 43: 67.
1941	ziar	Dedrick SC, Ramirez-Rico J. Potency and stability of frozen urokinase solutions in syringes. Am J Health-Syst Pharm 2004 ; 61: 1586-1589.
2050	ziar	Kohles JD, Weld M, Asa?d H, Gunning P, Reid Sterrett J, Debari VA. Stability of reconstituted urokinase solutions. Current Ther Res 2000 ; 61: 1-6
5057	Laborator	ACTOSOLV 600 000 UI, poudre pour solution injectable/pour perfusion - Résumé des caractéristiques du produit. EUMEDICA PHARMACEUTICALS GMBH 2019

Mentions Légales